The Respiratory Medication Market growth is fueled by increasing air pollution levels, rising smoking rates, and aging populations susceptible to respiratory conditions. The COVID-19 pandemic heightened awareness of respiratory health, accelerating research and development investments. Government initiatives to improve COPD and asthma management further stimulate market expansion. Biologic...

The Respiratory Medication Market is positioned at a critical juncture where scientific understanding of respiratory disease pathophysiology, technological capabilities for therapeutic intervention, and global health priorities are converging to create sustained demand for innovative pharmaceutical solutions. Respiratory diseases collectively constitute one of the leading causes of death and...